Critical appraisal:Gojkovič-Horvat A, Jančar B, Blas M, Zumer B, Karner K, Hočevar M, et al 2012 2

From Cancer Guidelines Wiki

Risk of bias assessment: cohort study

Subject selection
"New technology" group
Representative of eligible patients.
Comparison group
Representative of eligible patients
Comparability of groups on demographic characteristics and clinical features
Not comparable but adjusted analysis used
Measurement of outcomes
Outcome measures blind to technology used
No, but objective measures used
Same method of measurement used across comparison groups
Completeness of follow-up
Was follow-up complete and were all patients included in the analysis?
Yes (follow-up >95%) or survival analysis using all patients
Overall risk of bias
Moderate risk of bias Additional comments: Please replace this text and include any additional comments in regards to your risk of bias rating

Jutta's tick icon.png This appraisal has been completed.

Gojkovič-Horvat A, Jančar B, Blas M, Zumer B, Karner K, Hočevar M, et al. Adjuvant radiotherapy for palpable melanoma metastases to the groin: when to irradiate? Int J Radiat Oncol Biol Phys 2012 May 1;83(1):310-6 Available from:
Assigned to
Topic area
Clinical question
Form:Quality appraisal cohort

Section below only relevant for Cancer Council Project Officer

Edit appraisal assignment